Focus
Non era una colangite infettiva
It was not infectious cholangitis
Martina Mainetti, Federico Marchetti
UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
Maggio 2020 - pagg. 317 -318
Abstract
A picture of the onset of “hepatocolangitis” especially if with dilatation of the biliary tract must necessarily make one think of primary sclerosing cholangitis (PSC). The suspicion of PSC must always make one think of concomitant chronic inflammatory bowel disease (IBD) even if asymptomatic or paucisymptomatic. In fact, in 70-90% of PSCs it is associated with IBD, generally with an ulcerative rectocolitis phenotype. In these cases the dosage of faecal calprotectin can be an indicator of suspicion in case of positivity. In the same way, in a child/adolescent diagnosed with IBD (especially if they present with URC), transaminases and especially GGTs should always be monitored because one in 10 cases may have a concomitant PSC picture during their lifetime. Sometimes PSC can overlap clinical, biochemical and histological features with autoimmune hepatitis and configure a framework known as autoimmune sclerosing cholangitis (ASC). The prognosis of PSC is more benign in the child than in the adult (although burdened with complications), but the diagnosis (cholangio-MRI and liver biopsy), as well as the treatment (with ursodeoxycholic acid and immunosuppressants), must be timely. The paper reports the case of a 9-year-old child with an initial diagnosis of infectious hepatocolangitis which turned out to be a primary sclerosing cholangitis, with an associated picture of ulcerative rectocolitis little expressed from clinical and biopsy points of view.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Chandrakumar A, Loeppky R, Deneau M, El-Matary W. Inflammatory bowel disease in children with elevated serum gamma glutamyltransferase levels. J Pediatr 2019;215: 144-51.
2. Valentino PL, Feldman B.M, Walters TD, et al. Abnormal liver biochemistry is common in pediatric inflammatory bowel disease: prevalence and associations. Inflamm Bowel Dis 2015;21:2848-56.
3. Mieli-Vergani G, Vergani D. Sclerosing cholangitis in children and adolelescents. Clin Liver Dis 2016;20(1):99-111.
4. Ricciuto A, Kamath B.M, Griffiths AM. The IBD and PSC Phenotypes of PSC-IBD. Curr Gastroenterol Rep 2018;20(4):16.
5. Bramuzzo M. Gastroenterologia pediatrica: quattro casi per quattro messaggi. Medico e Bambino 2018;37:315-8.
6. Deneau M, Jensen MK, Holmen J, Williams MS, Book L.S, Guthrey SL. Primary sclerosis cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatol 2013;58:1392-400.
7. Gregorio GV, Portmann B, Karani J, et al. Autoimmune epatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33(3): 544-53.
8. Kerkar N, Chan A. Autoimmune hepatitis, sclerosing cholangitis, and autoimmune sclerosing cholangitis or overlap syndrome. Clin Liver Dis 2018;22(4):689-702.
9. Sciveres M. Colangite sclerosante primitiva: quali novità? Giorn Gastr Epatol Nutr Ped 2017;9:178-81.
10. Deneau M, Perito E, Ricciuto A. Ursodeoxycholic acid therapy in pediatric primary sclerosing cholangitis: predictors of gamma glutamyltransferase normalization and favorable clinical course. J Pediatr 2019;209:92-6.
11. Deneau MR, El-Matary W, Valentino PL, et al. The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology 2017;66:518-27.
Corrispondenza: mmainetti111@gmail.com